View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 23, 2021

Prisma Health forms ten-year alliance with Siemens Healthineers

Siemens will implement new medical software and technology-based processes at Prisma Health.

Non-profit health company Prisma Health has entered a ten-year strategic alliance with Siemens Healthineers to strengthen healthcare services in South Carolina, US.

Free Report
img

2022: So far In Venture Capital

Global investment in 2022 has been majorly dominated by North America, Europe, and Asia Pacific, whereas the Middle East, and South and Central America have recorded low investments comparatively. In light of this, Europe and North America have been identified as the major destinations for Private Equity and Venture Capital (PE/VC) investments.   GlobalData’s whitepaper analyzes which sectors PE/VC firms have been investing in, looking at Technology, Media, and Telecom, with these sectors recording $356 billion and a deal volume of over 10,000 deals in 2022. Healthcare, Financial Services, Business & Consumer Services, and Construction sectors have also seen high investment activity by PE/VC firms, recording a deal value of over $70 billion each.   But what can this mean for you?   Understand how the Deals Database on GlobalData Explorer can be leveraged to:  
  • Track the Aggregate Investment Volumes in PE/VC-Stage firms across geographies and sectors, in addition to viewing the specific deals that drove these volumes
  • Identify the top investors already active in any sector-Geography combinations
  • Assess the Performance of Financial and Legal Advisors, supporting the Dealmaking in any segment of choice (Customizable League tables)
  • Understand what is driving the PE/VC fundraising (Deal Rationale)
  Consult our full report here and optimize your business strategy.
by GlobalData
Enter your details here to receive your free Report.

The partners will also focus on workforce development and innovating healthcare.

As part of the collaboration, new medical technology will be implemented at all Prisma Health sites.

The companies intend to enhance clinical services delivery, clinical technology and advanced analytics, as well as establish an Intelligence Insights Center to advance healthcare.

The Intelligence Insights Center aims to facilitate the use of Prisma Health’s patient data via computerised algorithms, also called artificial intelligence (AI).

This AI approach will allow more informed clinical decisions for physicians, in turn enabling quick and accurate diagnoses and treatment plans, while also aiding prediction or prevention of disease.

Another initiative will assess if computer-driven workflow tools can boost best practices of care and lower time-taking operational tasks. This will increase the time providers spend in patient interactions.

Prisma Health president and CEO Mark O’Halla said: “Working together brings breakthrough opportunities to enhance clinical care through the latest clinical technology, streamlining our clinical and business processes, and bringing new advances in disease prevention, early diagnosis and treatment.”

Working with Prisma Health physicians, Siemens will implement new medical software and technology-based processes to bolster clinical outcomes and operational efficiency at the health company.

Prisma Health runs 18 acute care and specialty hospitals with a total of 2,947 beds and nearly 300 outpatient sites. It has approximately 5,000 employed and clinically integrated network physicians and providers.

Siemens Healthineers Americas president and head David Pacitti said: “This long-term Value Partnership with Prisma Health is our company’s largest in the US and represents the collective power of our two organisations and our shared vision of improving patient care.”

Hospitals can leverage this partnership model to improve business processes and boost capabilities, Siemens said. Such alliances involve the complete portfolio of Siemens.

In January this year, Siemens agreed to supply critical medical equipment to UK’s hospital operator Manchester University NHS Foundation Trust (MFT).

Related Companies

Free Report
img

2022: So far In Venture Capital

Global investment in 2022 has been majorly dominated by North America, Europe, and Asia Pacific, whereas the Middle East, and South and Central America have recorded low investments comparatively. In light of this, Europe and North America have been identified as the major destinations for Private Equity and Venture Capital (PE/VC) investments.   GlobalData’s whitepaper analyzes which sectors PE/VC firms have been investing in, looking at Technology, Media, and Telecom, with these sectors recording $356 billion and a deal volume of over 10,000 deals in 2022. Healthcare, Financial Services, Business & Consumer Services, and Construction sectors have also seen high investment activity by PE/VC firms, recording a deal value of over $70 billion each.   But what can this mean for you?   Understand how the Deals Database on GlobalData Explorer can be leveraged to:  
  • Track the Aggregate Investment Volumes in PE/VC-Stage firms across geographies and sectors, in addition to viewing the specific deals that drove these volumes
  • Identify the top investors already active in any sector-Geography combinations
  • Assess the Performance of Financial and Legal Advisors, supporting the Dealmaking in any segment of choice (Customizable League tables)
  • Understand what is driving the PE/VC fundraising (Deal Rationale)
  Consult our full report here and optimize your business strategy.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management